|
Catalog Number 08P07-22 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/28/2023 |
Event Type
malfunction
|
Event Description
|
The customer observed false nonreactive alinity i hiv ag/ab combo result on a 75-year-old female patient whose previous result was positive.The following data was provided: (b)(6) 2023 alinity i hiv ag/ab combo result = nonreactive.Another method (dynascreen) result = negative.Another method (cleia method) result = awaiting results.Previous results: (b)(6) 2023 alinity i hiv ag/ab combo result = 23.7 s/co (reactive).Another method (cleia method) result = positive.Pcr was performed, but the results could not be confirmed.On (b)(6) 2023, the customer provided additional information.The sample was sent to the reference lab and the following results were obtained: reproducibility result = negative.Immunochromatography method = negative for both hiv-1 and hiv-2.No impact to patient management was reported.
|
|
Manufacturer Narrative
|
Section e1 - address 1: complete address: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, alinity i hiv ag/ab combo, list number 08p07-22, that has a similar product distributed in the us, list number 08p07-21/-31.
|
|
Manufacturer Narrative
|
The complaint investigation for false nonreactive alinity i hiv ag/ab combo results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.In-house testing of retained reagent kit was also completed.Return testing was not performed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot numbers 49446be00 and complaint issue.Labeling was reviewed and found to be adequate.In-house testing of a retained reagent kit of the complaint lot was performed, and specifications were met which indicates the product is performing as expected.In addition, the clinical sensitivity was evaluated by testing two commercially available seroconversion panels (zeptometrix hiv 9013 and hiv 9016).The seroconversion panel results were compared to hiv test results provided by zeptometrix and the reagent lots detected the same bleeds as reactive for the seroconversion panels.Based on these data, it showed that the sensitivity performance of the complaint lot is not adversely affected.Based on our investigation, the alinity i hiv ag/ab combo reagent for lot 49446be00 is performing as intended, no systemic issue or deficiency was identified.
|
|
Event Description
|
The customer observed false nonreactive alinity i hiv ag/ab combo result on a 75-year-old female patient whose previous result was positive.The following data was provided: (b)(6) 2023 alinity i hiv ag/ab combo result = nonreactive.Another method (dynascreen) result = negative.Another method (cleia method) result = awaiting results.Previous results: (b)(6) 2023 alinity i hiv ag/ab combo result = 23.7 s/co (reactive).Another method (cleia method) result = positive.Pcr was performed, but the results could not be confirmed.On (b)(6) 2023, the customer provided additional information.The sample was sent to the reference lab and the following results were obtained: reproducibility result = negative.Immunochromatography method = negative for both hiv-1 and hiv-2.No impact to patient management was reported.
|
|
Search Alerts/Recalls
|
|
|